skip to primary navigationskip to content

Nuffield Research Placement 2017

Last summer, Abbey spent 4 weeks in Kevin Chalut's group for her Nuffield research placement. During that time, she worked with Celine Labouesse and other members of the group on the differentiation dynamics of mouse embryonic stem cells on custom-made soft substrates. Abbey had the opportunity to learn how to fabricate soft and stiff hydrogels, take care of cells, and use standard tools such as flow cytometry and immunostaining.

It was great to have Abbey work with me, and it really helped it getting some projects going which might have otherwise stayed shelved. I am grateful for her help, and enjoyed the opportunity to discuss my work with a non-specialist science enthusiast.

Celine Labouesse, Research Associate, Chalut Group

RSS Feed Latest news

Stem Cell Institute Group Leaders elected as EMBO members

Jul 07, 2020

Two Cambridge Stem Cell Institute Group Leaders are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).

Institute PIs awarded university promotions

Jun 26, 2020

Many congratulations to our institute and affiliate PIs who have been awarded promotions through the University’s Academic Promotions process recognising their outstanding work.

Potentially cancerous cells kept in check by competitive neighbours, study of oesophagus finds

May 18, 2020

The expansion of ‘mutant’ cells that could lead to cancer is often kept in check by their neighbours, research from the Wellcome Sanger Institute, the University of Cambridge and their collaborators has found. The team discovered that when equally-matched cells in the oesophagus of mice coincided, they acted as a brake on one another’s growth.

Professor Ludovic Vallier elected to the Fellowship of the Academy of Medical Sciences

May 13, 2020

The Academy of Medical Sciences has elected 50 of the UK’s most prominent biomedical and health scientists to their Fellowship.

Key nose cells identified as likely COVID-19 virus entry points

Apr 23, 2020

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells.

View all news

The Cambridge Stem Cell Institute is a world-leading centre for stem cell research.

Our mission: to transform human health through a deep understanding of stem cell biology.

 

The Institute is funded by Wellcome and the Medical Research Council.

         

 

Sign up to our newsletter to stay up-to-date with news and events from the Cambridge stem cell community.